|
CCPG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.39300000004494E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.227300E-04 |
| Normal-vs-Stage2 |
4.996300E-02 |
| Normal-vs-Stage3 |
5.18930000081852E-08 |
| Normal-vs-Stage4 |
1.74330000002332E-06 |
| Stage1-vs-Stage2 |
7.227800E-01 |
| Stage1-vs-Stage3 |
4.020700E-03 |
| Stage1-vs-Stage4 |
3.174400E-02 |
| Stage2-vs-Stage3 |
4.866000E-02 |
| Stage2-vs-Stage4 |
5.142000E-02 |
| Stage3-vs-Stage4 |
7.793200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.73959999972118E-07 |
| Normal-vs-AfricanAmerican |
7.819700E-02 |
| Normal-vs-Asian |
1.984910E-04 |
| Caucasian-vs-AfricanAmerican |
2.124800E-01 |
| Caucasian-vs-Asian |
9.713600E-01 |
| AfricanAmerican-vs-Asian |
2.287200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.93959999997373E-06 |
| Normal-vs-Female |
2.14530000000046E-05 |
| Male-vs-Female |
3.411000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.413200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.16459999999863E-05 |
| Normal-vs-Age(61-80Yrs) |
6.59070000019746E-07 |
| Normal-vs-Age(81-100Yrs) |
1.119860E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.496800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.216810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.381200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.053000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.035000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.557800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.43789999995647E-06 |
| Classical-VS-Follicular |
6.201200E-01 |
| Classical-VS-Other |
1.628410E-01 |
| Classical-VS-Normal |
1.049390E-04 |
| Tall-VS-Follicular |
2.955800E-04 |
| Tall-VS-Other |
9.054600E-01 |
| Tall-VS-Normal |
3.44080319791829E-11 |
| Follicular-VS-Other |
4.709700E-02 |
| Follicular-VS-Normal |
1.745770E-02 |
| Other-VS-Normal |
1.021240E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.009730E-04 |
| Normal-vs-N1 |
2.26510000000957E-06 |
| N0-vs-N1 |
6.757600E-02 |
|
|
